Baltimore lab to make drug

February 12, 1993

In a sign the local biotech industry might be maturing, a Baltimore company has agreed to manufacture small quantities of an anti-cancer drug for a Virginia company.

Collaborations have been rare among local biotech companies, but Cel-Sci Corp., a publicly traded biotech company in Alexandria, signed a deal with Chesapeake Biological Laboratories yesterday.

"There is starting to be enough of a critical mass here to support some collaborations," said Geert Kersten, Cel-Sci chief operating officer. ". . . I was really surprised to find someone in the area. I thought we would have to go to Boston or California."

CBL expects to expand its work force by three or four trained people.

Baltimore Sun Articles
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.